RECRUITING

The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Mobile health (mHealth) will be used for early detection of oral cancer and pre-cancer lesions, and to improve awareness of oral cancer among the population and knowledge of oral cancer diagnosis among frontline health providers. This program is inclusive of long term surveillance to downstage oral cancer in India

Official Title

The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study

Quick Facts

Study Start:2024-07-30
Study Completion:2031-07-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06535867

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * All individuals aged above 18 years positive for habits (smoking and smokeless tobacco, chewing betel leaf, areca nut, paan masala, and/or regular use of alcohol)
  2. * Clinical signs/symptoms (non-healing ulcers, white/ red/red \& white patches in the mouth, restriction of mouth opening and swelling of the neck)
  3. * All individuals aged above 40 irrespective of habit/oral lesions
  1. * Individuals already diagnosed with oral cancer and undergoing treatment for oral cancer
  2. * Under treatment for tuberculosis or suffering from any acute illness/ debilitating systemic disorders

Contacts and Locations

Study Contact

Milind Rajadhyaksha, PhD
CONTACT
646-608-2364
rajadhym@mskcc.org
Aditi Sahu
CONTACT
646-608-1935
sahua@mskcc.org

Principal Investigator

Milind Rajadhyaksha, PhD
PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center

Study Locations (Sites)

Memorial Sloan Kettering Cancer Center (All protocol activites)
New York, New York, 10065
United States

Collaborators and Investigators

Sponsor: Memorial Sloan Kettering Cancer Center

  • Milind Rajadhyaksha, PhD, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-07-30
Study Completion Date2031-07-30

Study Record Updates

Study Start Date2024-07-30
Study Completion Date2031-07-30

Terms related to this study

Keywords Provided by Researchers

  • smoking
  • smoking, cigarette
  • smoking, tobacco
  • smokeless tobacco
  • betel leaf
  • areca nut
  • paan masala
  • alcohol use
  • Memorial Sloan Kettering Cancer Center
  • 24-148

Additional Relevant MeSH Terms

  • Smoking
  • Smoking, Cigarette
  • Smoking, Tobacco
  • Betel Chewer's Mucosa
  • Tobacco Use
  • Tobacco Smoking
  • Alcohol Drinking
  • Smokeless Tobacco Hyperkeratosis